Yoshiyuki Wada

5.1k total citations
117 papers, 2.6k citations indexed

About

Yoshiyuki Wada is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, Yoshiyuki Wada has authored 117 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hepatology, 33 papers in Oncology and 31 papers in Surgery. Recurrent topics in Yoshiyuki Wada's work include Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers) and Liver Disease Diagnosis and Treatment (18 papers). Yoshiyuki Wada is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (41 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers) and Liver Disease Diagnosis and Treatment (18 papers). Yoshiyuki Wada collaborates with scholars based in Japan, United States and France. Yoshiyuki Wada's co-authors include Hirotomo Saitsu, Yuko Takami, Tomoki Ryu, Yoshinobu Nodasaka, Ryuichi Fujisawa, Yoshinori Kuboki, Noriaki Futakawa, Masaki Tateishi, Masatoshi Kudo and Akira Kuroda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Yoshiyuki Wada

111 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiyuki Wada Japan 24 795 647 513 451 425 117 2.6k
Yasushi Matsuzaki Japan 28 911 1.1× 466 0.7× 560 1.1× 749 1.7× 661 1.6× 114 2.9k
Shogo Tanaka Japan 30 1.1k 1.3× 1.0k 1.6× 1.5k 2.9× 675 1.5× 406 1.0× 220 3.5k
G. Borroni Italy 27 328 0.4× 319 0.5× 282 0.5× 793 1.8× 287 0.7× 165 2.7k
Kyoichi Inoue Japan 28 2.1k 2.6× 577 0.9× 795 1.5× 1.3k 2.9× 943 2.2× 104 4.0k
Steven P. O’Hara United States 30 1.1k 1.4× 367 0.6× 1.0k 2.0× 766 1.7× 846 2.0× 53 3.1k
Motoki Nakamura Japan 25 450 0.6× 414 0.6× 275 0.5× 548 1.2× 470 1.1× 93 2.4k
Unne Stenram Sweden 29 458 0.6× 564 0.9× 705 1.4× 514 1.1× 748 1.8× 208 3.3k
Elizabeth J. Ryan Ireland 33 369 0.5× 731 1.1× 215 0.4× 758 1.7× 684 1.6× 92 3.4k
Chi‐Neu Tsai Taiwan 29 205 0.3× 653 1.0× 232 0.5× 260 0.6× 1.1k 2.5× 86 2.7k
Florian W. R. Vondran Germany 30 1.1k 1.4× 298 0.5× 639 1.2× 1.0k 2.3× 534 1.3× 154 2.7k

Countries citing papers authored by Yoshiyuki Wada

Since Specialization
Citations

This map shows the geographic impact of Yoshiyuki Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiyuki Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiyuki Wada more than expected).

Fields of papers citing papers by Yoshiyuki Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiyuki Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiyuki Wada. The network helps show where Yoshiyuki Wada may publish in the future.

Co-authorship network of co-authors of Yoshiyuki Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiyuki Wada. A scholar is included among the top collaborators of Yoshiyuki Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiyuki Wada. Yoshiyuki Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ueshima, Kazuomi, Masatoshi Kudo, Kaoru Tsuchiya, et al.. (2023). Primary analysis of a phase II study of atezolizumab plus bevacizumab for TACE-unsuitable patients with tumor burden beyond up-to-seven criteria in intermediate-stage hepatocellular carcinoma: REPLACEMENT study.. Journal of Clinical Oncology. 41(16_suppl). 4125–4125. 2 indexed citations
2.
Sato, Yo, Takanobu Hara, Yuko Takami, et al.. (2019). Conversion surgery for initially unresectable carcinoma of the ampulla of Vater following pathological complete response to chemotherapy: a case report. SHILAP Revista de lepidopterología. 5(1). 122–122.
3.
Kudo, Masatoshi, Kenta Motomura, Yoshiyuki Wada, et al.. (2019). First-line avelumab + axitinib in patients with advanced hepatocellular carcinoma: Results from a phase 1b trial (VEGF Liver 100).. Journal of Clinical Oncology. 37(15_suppl). 4072–4072. 53 indexed citations
4.
5.
Wada, Yoshiyuki, et al.. (2016). Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. OncoTargets and Therapy. 9. 937–937. 11 indexed citations
6.
7.
Ryu, Tomoki, Yuko Takami, Norifumi Tsutsumi, et al.. (2016). Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism. Surgery Today. 47(5). 548–554. 15 indexed citations
8.
Ryu, Tomoki, Yuko Takami, Masaki Tateishi, Yoshiyuki Wada, & Hirotomo Saitsu. (2012). Efficacy of COX-2 inhibitor, Meloxicam, for recurrent hepatocellular carcinoma after curative treatment. Kanzo. 53(11). 781–783. 1 indexed citations
9.
Ryu, Tomoki, Yuko Takami, Masaki Tateishi, Yoshiyuki Wada, & Hirotomo Saitsu. (2012). Strategies for the treatment of liver metastases from gastric cancer: hepatic resection and microwave coagulo-necrotic therapy (MCN). Journal of Microwave Surgery. 30(0). 97–102. 1 indexed citations
10.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, & Hirotomo Saitsu. (2011). A case of synchronous double cancer of the common bile duct and papilla of vater. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72(12). 3135–3139.
11.
Takami, Yuko, et al.. (2011). A CASE OF PERITONEAL MESOTHELIOMA PRESENTED WITH INVASION TO PERICARDIA AND THE LIVER. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72(3). 640–646. 1 indexed citations
12.
Shigematsu, Hideo, Kazuhiro Yoshida, Yuichi Sanada, et al.. (2009). Rapamycin enhances chemotherapy‐induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells. International Journal of Cancer. 126(11). 2716–2725. 29 indexed citations
13.
Wada, Yoshiyuki, et al.. (2008). The Suppressive Effect of Enamel Matrix Derivative on Osteocalcin Gene Expression of Osteoblasts Is Neutralized by an Antibody Against TGF‐β. Journal of Periodontology. 79(2). 341–347. 21 indexed citations
14.
Takami, Yuko, et al.. (2008). The strategy for the treatment of hepatocellular carcinoma: Hr and/or MCN. Journal of Microwave Surgery. 26. 73–78. 2 indexed citations
15.
Wada, Yoshiyuki, et al.. (2007). Kidney Metastasis of Resected Early Gastric Carcinoma: Report of a Case. Surgery Today. 37(3). 248–250. 1 indexed citations
16.
Wada, Yoshiyuki, et al.. (1996). Intestinal adenocarcinoma with neuroendocrinecells in a clouded leopard (Neofelis nebulosa). Journal of Comparative Pathology. 115(3). 305–310. 3 indexed citations
17.
Futakawa, Noriaki, Seiichi YAMAGATA, Yoshiyuki Wada, et al.. (1994). Different Clinicopathologic Findings in Two Histologic Types of Carcinoma of Papilla of Vater. Japanese Journal of Cancer Research. 85(2). 161–166. 174 indexed citations
18.
Wada, Yoshiyuki, et al.. (1994). Candidiasis caused by Candida glabrata in the forestomachs of a calf. Journal of Comparative Pathology. 111(3). 315–319. 6 indexed citations
19.
Nagao, Takeshi, et al.. (1991). Surgical experience with nonparasitic cysts of the liver —The characteristics and constituents of cyst fluid—. Surgery Today. 21(5). 521–527. 10 indexed citations
20.
Nakao, Norio, et al.. (1984). [Indication of transcatheter arterial embolization in hepatocellular carcinoma with liver cirrhosis evaluated from the liver function tests].. PubMed. 81(9). 1995–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Matsuzaki Breakdown of academic impact, for papers by Shogo Tanaka Breakdown of academic impact, for papers by G. Borroni Breakdown of academic impact, for papers by Kyoichi Inoue Breakdown of academic impact, for papers by Steven P. O’Hara Breakdown of academic impact, for papers by Motoki Nakamura Breakdown of academic impact, for papers by Unne Stenram Breakdown of academic impact, for papers by Elizabeth J. Ryan Breakdown of academic impact, for papers by Chi‐Neu Tsai Breakdown of academic impact, for papers by Florian W. R. Vondran
Rankless by CCL
2026